Can you keep weight off after stopping GLP-1 drugs for good?

What did @drjonesdc actually say?

The creator describes a patient who regained all her weight after insurance cut her GLP-1 coverage abruptly, then relost it without the medication after following a structured protocol. The claim is that "her set point actually moved" through a combination of fasting, resistance training, high protein intake, and what the creator calls a "metabolic reset" targeting insulin resistance. She is now on "micro-dosing" for maintenance.

This is a specific, mechanistic story: GLP-1 drugs created a window, the patient used that window to build lasting physiological change, and the weight stayed off because of the lifestyle work, not the drug. That is a meaningful and testable claim, not just wellness platitudes.

Does the science back this up?

Partially, yes. The weight regain data after stopping GLP-1 therapy is rock solid. The STEP 1 extension trial (Wilding et al., 2022, NEJM) found participants regained roughly two-thirds of lost weight within a year of stopping semaglutide. That part of the story checks out completely.

The "set point" language is where things get murkier. Body weight regulation is real and involves leptin signaling, adaptive thermogenesis, and appetite-regulating hormones, but "set point" as a fixed biological target that can be permanently relocated is an oversimplification. Research from Sumithran et al. (2011, NEJM) showed appetite hormones like ghrelin remained elevated a year after weight loss, suggesting the body continues defending its prior weight. Resistance training and protein do improve metabolic rate and muscle mass (Stokes et al., 2018, Obesity Reviews), which matters. But calling this a permanent set point shift overstates what we can currently prove.

What did they get wrong (or right)?

Credit where it is due: the core argument that GLP-1 therapy should be used as a window to build sustainable habits is defensible and aligns with how many obesity medicine specialists think about long-term management. The emphasis on insulin resistance, protein targets, and resistance training reflects evidence-based practice.

The problems are real, though. First, "metabolic reset" and "crash metabolism" are not clinical terms. They sound specific but mean nothing measurable. Second, the claim that the set point "actually moved" is stated as fact based on one anecdote. That is not how you establish a physiological mechanism. Third, the transcript never addresses that this patient outcome could simply reflect someone who was highly adherent, already had reversible insulin resistance, and had the resources for a supervised protocol. Most patients stopping GLP-1 therapy abruptly do not achieve this outcome, and presenting one success story without that context is misleading by omission.

What should you actually know?

If you are on a GLP-1 medication and worried about coverage loss or stopping, the science says the risk of regain is high and real. That is not a reason to panic, but it is a reason to use the time on medication intentionally. Behavioral interventions during GLP-1 therapy do improve long-term outcomes. A 2023 analysis by Rubino et al. (Obesity) found that combining structured lifestyle intervention with semaglutide produced better weight maintenance after drug discontinuation than medication alone.

What you should be skeptical of is any protocol sold as the fix for everyone who regains weight after stopping. Insulin resistance, thyroid function, sleep, stress, socioeconomic factors, and medication history all affect outcomes in ways one viral TikTok cannot address. The creator is right that GLP-1 drugs are tools, not cures. They are wrong to imply a proprietary "protocol" reliably produces permanent change. Talk to a licensed provider about your specific situation before acting on any step-by-step guide in a comment section.